Form 8-K - Current report:
SEC Accession No. 0001628280-26-046136
Filing Date
2026-06-30
Accepted
2026-06-30 07:31:57
Documents
13
Period of Report
2026-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20260628.htm   iXBRL 8-K 32435
2 EX-99.1 exhibit991-ioverapressrele.htm EX-99.1 24711
6 PACIRA BIOSCIENCES LOGO pacirabiosciencestmrgba.jpg GRAPHIC 468777
  Complete submission text file 0001628280-26-046136.txt   783263

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20260628.xsd EX-101.SCH 1792
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20260628_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20260628_pre.xml EX-101.PRE 12518
17 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20260628_htm.xml XML 2831
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 261137983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)